Although IL-4- and IL-13-producing Th2 cells have been associated with increased tumor growth in humans (233) and in animal models using IFN-γ−/−and IL-4−/− deficient mice (234, 235), Th17 cells seem to be the most aggressive orchestrators of chronic inflammation during IBD and have a significant role in the initiation of CRC. This evidence concerns the gene IL13 and colorectal carcinoma.